Evidence map›Paper›PMID 26510884›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Martin Matejovic, Can Ince, Lakhmir S Chawla, Roland Blantz, Bruce A Molitoris, Mitchell H Rosner, Mark D Okusa, John A Kellum, Claudio Ronco, ADQI XIII Work Group

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Martin MatejovicFirst Medical Department and Biomedical Centre, Faculty of Medicine in Plzen, Charles University in Prague, Teaching Hospital in Plzen, Plzen, Czech Republic;
Can InceDepartment of Intensive Care, Erasmus Medical Center University Hospital, Rotterdam, The Netherlands;
Lakhmir S ChawlaDepartment of Medicine, Division of Intensive Care Medicine and Division of Nephrology, Veterans Affairs Medical Center, Washington, DC;
Roland BlantzNephrology-Hypertension Division, University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System, San Diego, California;
Bruce A MolitorisDepartment of Medicine, Division of Nephrology and Department of Cellular and Integrative Physiology, Indiana University School of Medicine and the Rouderbush Veterans Affairs Medical Center, Indianapolis, Indiana;
Mitchell H RosnerDivision of Nephrology, Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia Health System, Charlottesville, Virginia; MHR9R@hscmail.mcc.virginia.edu.
Mark D OkusaDivision of Nephrology, Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia Health System, Charlottesville, Virginia;
John A KellumCenter for Critical Care Nephrology and Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and.
Claudio RoncoDepartment of Nephrology Dialysis and Transplantation, San Bortolo Hospital and the International Renal Research Institute, Vicenza, Italy.
ADQI XIII Work Group

Funding

Ultrasound for Non-Invasive Prevention of Acute Kidney InjuryR01DK105133 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2015 to 2019
$2.4M
NIDDK NIH HHS R01 DK105133
6 · The paper itself

Abstract

Novel therapeutic interventions are required to prevent or treat AKI. To expedite progress in this regard, a consensus conference held by the Acute Dialysis Quality Initiative was convened in April of 2014 to develop recommendations for research priorities and future directions. Here, we highlight the concepts related to renal hemodynamics in AKI that are likely to reveal new treatment targets on investigation. Overall, we must better understand the interactions between systemic, total renal, and glomerular hemodynamics, including the role of tubuloglomerular feedback. Furthermore, the net consequences of therapeutic maneuvers aimed at restoring glomerular filtration need to be examined in relation to the nature, magnitude, and duration of the insult. Additionally, microvascular blood flow heterogeneity in AKI is now recognized as a common occurrence; timely interventions to preserve the renal microcirculatory flow may interrupt the downward spiral of injury toward progressive kidney failure and should, therefore, be investigated. Finally, development of techniques that permit an integrative physiologic approach, including direct visualization of renal microvasculature and measurement of oxygen kinetics and mitochondrial function in intact tissue in all nephron segments, may provide new insights into how the kidney responds to various injurious stimuli and allow evaluation of new therapeutic strategies.

Indexed as

HemodynamicsRenal CirculationAcute Kidney InjuryBiomedical ResearchHumansacute renal failureclinical nephrologyhemodynamics and vascularregulation

Identifiers

PMID26510884
PMCPMC4696587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.